• Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: August 2015

    Vitamin D research was once again a recurring news story this month, with more studies linking lack of vitamin D to MS. Also widely reported was the news Novartis bought GlaxoSmithKline’s remaining rights to Ofatumumab, an investigational multiple sclerosis medicine, for up to $1 billion. Highlight! Gene study finds link between multiple sclerosis and low vitamin D Gene study backs up link between vitamin D and multiple sclerosis risk Low levels of vitamin D may cause multiple sclerosis Vitamin D deficiency direct cause of multiple sclerosis (MS): Study

  • Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: July 2015

    Because of the summer holidays, less positive news has filtered through. Either way, enjoy, and hopefully more next month! Research Gene Regulating Treatment Response in Multiple Sclerosis Identified New Study Evaluates The Role of MRI in Monitoring MS Progression Multiple Sclerosis Nano-Drugs in Liposomes Could Treat Multiple Sclerosis Altered Immune Cells in Relapsing Remitting Multiple Sclerosis Patients Cause Reduced Immune Capacity MS Study Uses Findings on Quality of Life Issues To Develop New Confidence-Building Intervention Nutra Pharma Working on Pediatric MS Treatment Based on Venom Multiple Sclerosis News Today Identifying MS Gene Mutations Could Make Personalized Treatment Possible Multiple Sclerosis … Brain Scan To Detect Multiple Sclerosis, Other Brain Abnormalities Why medical research matters New MS Study Shows TYSABRI Improves Cognitive Impairment AB Science announces successful non futility test for…

  • MS,  Multiple Sclerosis,  Trigeminal Neuralgia,  World MS Day

    Hope cures old wounds

    “The illness is mine, but the tragedy theirs,” when asked how my family feels about my condition. When I entered the MS academy, I read the small print and knew it wouldn’t be a 365-day holiday. However, I tolerate MS. There’s no resentment or blame, no more heartache, guilt or doubt. I find solace in seeing science produce more and better research results and medication. Clinical trials are moving forward at a pace that will eventually lead to an easier life with an illness that is as fickle as MS."

  • Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: April 2015

    Research news Miconazole and clobetasol may be effective as multiple sclerosis therapies Drug Derived From Sea Anemone Shows Promise Against Psoriasis, MS Novel Drug From Nature Shows Early Promise ‘Brainbow’ illuminates cellular connections MS Association of America releases 2015 multiple sclerosis research update B Vitamin Promising in Progressive Multiple Sclerosis Phenytoin protects against optical damage in multiple sclerosis Could Eczema Cream Be Used for Treating Multiple Sclerosis? URMC Start-up Takes Aim at Memory and Cognitive Problems Controversial stem cell treatment for multiple sclerosis Key Cytokine Discovery May Shape Future MS Treatment The UpBeat: One of the ‘super heroes’ encouraged by promising MS research Drugs that activate brain stem cells may reverse multiple sclerosis Novel Mechanism May Prevent Onset of MS in Immune Cells French firm announces multiple sclerosis drug breakthrough…

  • Barts MS Blog,  Monthly MS News,  MS,  Multiple Sclerosis

    MS News: March 2015

    Yes, here’s the March edition already! I will try and update the post each week as it will be a busy month ahead with Brain Awareness Week in Ireland, National MS Education and Awareness Month is an effort by the Multiple Sclerosis Foundation (MSF) and the US National Multiple Sclerosis Society’s MS Awareness Week. The big news this week is/has been all about coffee. According to the American Academy of Neurology, drinking coffee may be associated with a lower risk of developing multiple sclerosis (MS). Coffee intake may protect against MS, supporting the idea that the drug may have protective effects for the brain,” said study author Ellen Mowry, MD, MCR, with Johns Hopkins University School of Medicine in Baltimore and a member of the American Academy of Neurology. While…